Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2021 May 11

PMID 33972455

Citations 8

Authors

Christopher M Chandler

Lori Bourassa

Patrick C Mathias

Alexander L Greninger

Affiliations

Soon will be listed here.

Citing Articles

Testing for SARS-CoV-2: lessons learned and current use cases.

Theel E, Kirby J, Pollock N Clin Microbiol Rev. 2024; 37(2):e0007223.

PMID: 38488364 PMC: 11237512. DOI: 10.1128/cmr.00072-23.

Pre-Operative SARS-CoV-2 Testing in Asymptomatic Heart Transplantation Recipients.

Zwetsloot P, Smit W, Van der Kaaij N, Szymanski M, van der Meer M, van Laake L Biomedicines. 2023; 11(8).

PMID: 37626599 PMC: 10452735. DOI: 10.3390/biomedicines11082103.

Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.

Hohl C, Hau J, Vaillancourt S, Grant J, Brooks S, Morrison L JAMA Netw Open. 2022; 5(10):e2236288.

PMID: 36223119 PMC: 9557877. DOI: 10.1001/jamanetworkopen.2022.36288.

Rapid Antigen Assays for SARS-CoV-2: Promise and Peril.

Truong T, Bard J, Butler-Wu S Clin Lab Med. 2022; 42(2):203-222.

PMID: 35636822 PMC: 8894733. DOI: 10.1016/j.cll.2022.03.001.

Biosensor detection of airborne respiratory viruses such as SARS-CoV-2.

Breshears L, Nguyen B, Mata Robles S, Wu L, Yoon J SLAS Technol. 2022; 27(1):4-17.

PMID: 35058206 PMC: 8720388. DOI: 10.1016/j.slast.2021.12.004.

References

Burd E . Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev. 2010; 23(3):550-76. PMC: 2901657. DOI: 10.1128/CMR.00074-09. View

Lieberman J, Pepper G, Naccache S, Huang M, Jerome K, Greninger A . Comparison of Commercially Available and Laboratory-Developed Assays for Detection of SARS-CoV-2 in Clinical Laboratories. J Clin Microbiol. 2020; 58(8). PMC: 7383518. DOI: 10.1128/JCM.00821-20. View

Lin L, Carlquist J, Sinclair W, Hall T, Lopansri B, Bennett S . Experience With False-Positive Test Results on the TaqPath Real-Time Reverse Transcription-Polymerase Chain Reaction Coronavirus Disease 2019 (COVID-19) Testing Platform. Arch Pathol Lab Med. 2020; 145(3):259-261. DOI: 10.5858/arpa.2020-0612-LE. View

Tsuboi H, Kasamatsu Y, Matsubara S, Sasao A, Kunimitsu K, Munakata N . Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment. J Infect Chemother. 2021; 27(7):1072-1075. PMC: 7755570. DOI: 10.1016/j.jiac.2020.12.018. View